Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO ...

Pharmaceutical giant Eli Lilly (NYSE: LLY ... board of directors approved a $15 billion stock buyback program. CFO Lucas Montarce said of the share buyback: As Lilly has entered into a period ...

(Bloomberg) -- Eli Lilly & Co.’s fourth-quarter revenue ... precision than market concerns,” Chief Financial Officer Lucas Montarce said Tuesday in an interview with Bloomberg at the JPMorgan ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a global pharmaceutical firm, announced today the appointment of Lucas Montarce as the new Executive Vice President and Chief... Eli Lilly and ...

(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after ... As supply normalizes, Lilly's Chief Financial Officer Lucas Montarce said wholesalers did not seek to build up their stocks of ...

(Bloomberg) -- Eli Lilly & Co.’s fourth-quarter revenue fell short of ... “I’d call it more forecasting precision than market concerns,” Chief Financial Officer Lucas Montarce said Tuesday in an ...